Boston Bio Systems Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 417872,
    "name": "Boston Bio",
    "stock_name": "Boston Bio",
    "full_name": "Boston Bio Systems Ltd",
    "name_url": "stocks-analysis/boston-bio",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "7.27",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "7.27",
    "mcapval": "5.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531458,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 26,
    "indexname": "",
    "isin": "INE109B01019",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "3.45 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/boston-bio-417872-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "How has been the historical performance of Boston Bio?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-boston-bio-3704049",
        "imagepath": "",
        "date": "2025-11-15 00:23:21",
        "description": "Answer:\nThe historical performance of Boston Bio shows significant fluctuations in its financial metrics over the years, particularly in net sales and profitability.\n\nBreakdown:\nBoston Bio's net sales have seen a notable decline from 1.50 Cr in March 2016 to just 0.19 Cr in March 2025, with a complete absence of sales in the intervening years of March 2017, March 2018, and March 2024. The total operating income followed a similar trend, peaking at 1.50 Cr in March 2016 and dropping to 0.19 Cr in March 2025. The company has consistently reported no raw material costs or purchase of finished goods, indicating a lack of production activity. Total expenditure, however, increased to 0.74 Cr in March 2025, up from 0.14 Cr in March 2024, primarily driven by other expenses. This led to an operating profit (PBDIT) of -0.55 Cr in March 2025, reflecting a negative operating profit margin of -289.47%. The profit before..."
      },
      {
        "title": "Why is Boston Bio falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-boston-bio-fallingrising-3681594",
        "imagepath": "",
        "date": "2025-11-08 00:04:20",
        "description": "As of 07-Nov, Boston Bio Systems Ltd is experiencing a decline in its stock price, currently at 7.75, which represents a decrease of 0.37 or 4.56%. The stock has been underperforming, having fallen consecutively for the last two days and showing a total return of -8.82% over the past week. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. There has also been a significant drop in investor participation, with delivery volume on 06 Nov falling by 59.78% compared to the 5-day average. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.\n\nIn the broader market context, Boston Bio's short-term performance has significantly lagged behind the benchmark, the Sensex, which has only decreased by 0.86% over the same week. While the Sensex has sho..."
      },
      {
        "title": "Why is Boston Bio falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-boston-bio-fallingrising-3660066",
        "imagepath": "",
        "date": "2025-10-30 23:26:17",
        "description": "As of 30-Oct, Boston Bio Systems Ltd's stock price is currently at 8.39, reflecting an increase of 0.39 or 4.88%. The stock has shown strong performance recently, gaining 14.62% over the last three days and outperforming its sector by 3.91% today. The stock's delivery volume has also seen a significant rise of 160.05% compared to the 5-day average, indicating increased investor participation. Additionally, the stock is trading above its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below the 200-day moving average. There are no positive or negative factors explicitly mentioned, but the overall trends suggest a favorable sentiment towards the stock.\n\nIn the broader market context, Boston Bio's stock has outperformed the Sensex over the past week, with a return of +8.96% compared to the benchmark's slight decline of -0.18%. However, over the past month, while Boston Bio has gained +4..."
      },
      {
        "title": "Why is Boston Bio falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-boston-bio-fallingrising-3624323",
        "imagepath": "",
        "date": "2025-10-15 23:34:50",
        "description": "As of 15-Oct, Boston Bio Systems Ltd is experiencing a decline in its stock price, currently at 7.63, which reflects a decrease of 0.4 or 4.98%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total decline of 9.7% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The delivery volume has also decreased significantly, down by 42.38% compared to the 5-day average, suggesting a reduction in investor participation. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's recent movement.\n\nIn the broader market context, Boston Bio's performance over the past week shows a substantial decline of 15.88%, while the benchmark Sensex has increased by 1.02%. This stark contrast highlights the stock's underpe..."
      },
      {
        "title": "Why is Boston Bio falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-boston-bio-fallingrising-3611388",
        "imagepath": "",
        "date": "2025-10-10 23:19:23",
        "description": "As of 10-Oct, Boston Bio Systems Ltd's stock price is currently at 8.19, reflecting a decline of 0.43, or 4.99%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total drop of 9.7% during this period. Additionally, the stock's performance today has lagged behind its sector by 4.55%. In terms of returns, the stock has decreased by 7.67% over the past week and 1.80% over the past month, while there is no year-to-date or yearly return data available. Notably, investor participation has also diminished, with delivery volume dropping by 70.28% compared to the five-day average, indicating a lack of interest among investors.\n\nBroader Market Context: In contrast, the benchmark Sensex has shown positive movement, gaining 1.59% over the past week and 1.32% over the past month. This stark difference highlights the stock's underperformance relative to the broader mar..."
      },
      {
        "title": "Why is Boston Bio falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-boston-bio-fallingrising-3596838",
        "imagepath": "",
        "date": "2025-10-06 23:17:24",
        "description": "As of 06-Oct, Boston Bio Systems Ltd's stock price is currently at 9.00, reflecting an increase of 0.13 or 1.47%. The stock has shown strong performance recently, gaining 11.8% over the last three days and outperforming its sector by 2.03% today. Additionally, the stock has experienced a significant rise in investor participation, with delivery volume increasing by 294.72% compared to the five-day average. The stock's returns over the past week and month are also notable, with increases of 10.16% and 4.77%, respectively, indicating positive momentum. There is no information available regarding positive or negative factors that could influence the stock's movement.\n\nIn the broader market context, Boston Bio's short-term performance has significantly outpaced the benchmark, the Sensex, which has only risen by 1.77% over the past week and 1.34% over the past month. This strong relative performance suggests tha..."
      },
      {
        "title": "Why is Boston Bio falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-boston-bio-fallingrising-3572068",
        "imagepath": "",
        "date": "2025-09-25 23:28:15",
        "description": "As of 25-Sep, Boston Bio Systems Ltd is currently priced at 8.40, reflecting an increase of 0.07 or 0.84%. The stock has been on a positive trajectory, gaining for the last three days with a total return of 9.38% during this period. However, it has underperformed its sector by 1.54% today. In terms of benchmark performance, the stock has shown a weekly return of +0.60% compared to the Sensex's decline of -2.23%, and a monthly return of +2.44% against the Sensex's -0.58%. Notably, the stock's delivery volume has decreased significantly, falling by 53.15% against the 5-day average, indicating a drop in investor participation, which could be a concern for future price movements.\n\nBroader Market Context: The broader market context shows that the Medical Equipment/Supplies/Accessories sector has gained by 2.4%, which may provide a supportive backdrop for Boston Bio's recent gains. Despite this, the stock's perfo..."
      },
      {
        "title": "Why is Boston Bio falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-boston-bio-fallingrising-3562279",
        "imagepath": "",
        "date": "2025-09-23 23:30:43",
        "description": "As of 23-Sep, Boston Bio Systems Ltd's stock price is currently at 7.95, reflecting an increase of 0.27 or 3.52%. The stock has shown a trend reversal, gaining after two consecutive days of decline. Additionally, it has outperformed its sector by 3.94% today. The stock's delivery volume has significantly increased by 207.14% compared to the 5-day average, indicating rising investor participation. Although the stock is trading higher than its 50-day and 100-day moving averages, it remains lower than the 5-day, 20-day, and 200-day moving averages. There are no positive or negative factors provided to further explain the stock's recent movement.\n\nIn the broader market context, the stock's performance over the past week shows a decline of 0.62%, while the Sensex has decreased by only 0.34%, indicating that Boston Bio has underperformed relative to the benchmark in the short term. Over the past month, the stock ..."
      },
      {
        "title": "Why is Boston Bio falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-boston-bio-fallingrising-3555509",
        "imagepath": "",
        "date": "2025-09-22 23:21:04",
        "description": "As of 22-Sep, Boston Bio Systems Ltd is experiencing a decline in its stock price, currently at 7.65, which reflects a decrease of 0.17 or 2.17%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total return of -8.38% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The stock has also shown a significant drop in investor participation, with delivery volume plummeting by 93.94% against the 5-day average. There is no information available regarding positive or negative factors that could influence the stock's recent movement.\n\nIn the broader market context, Boston Bio's performance over the past week shows a decline of 4.97%, while the benchmark Sensex has increased by 0.46%. This stark contrast highlights the stock's underperformance relative to the market. Ov..."
      }
    ],
    "total": 66,
    "sid": "417872",
    "stock_news_url": "https://www.marketsmojo.com/news/boston-bio-systems-417872"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change of Company Name",
      "datetime": "27-Nov-2025",
      "details": "Intimation under Regulation 30 of the SEBI (LODR) Regulation 2015 - Change in the Name of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "15-Nov-2025",
      "details": "Intimitation under Regulation 47 for the publication of quarter and half year ended 30th September 2025.",
      "source": "BSE"
    },
    {
      "caption": "Considered And Approved The Standalone Un-Audited Financial Results Of The Company For The Quarter And Half Ended On 30Th September 2025.",
      "datetime": "14-Nov-2025",
      "details": "Unaudited Financial Results of the company for the quarter and half year ended on 30th September 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

How has been the historical performance of Boston Bio?

2025-11-15 00:23:21

Answer: The historical performance of Boston Bio shows significant fluctuations in its financial metrics over the years, particularly in net sales and profitability. Breakdown: Boston Bio's net sales have seen a notable decline from 1.50 Cr in March 2016 to just 0.19 Cr in March 2025, with a complete absence of sales in the intervening years of March 2017, March 2018, and March 2024. The total operating income followed a similar trend, peaking at 1.50 Cr in March 2016 and dropping to 0.19 Cr in March 2025. The company has consistently reported no raw material costs or purchase of finished goods, indicating a lack of production activity. Total expenditure, however, increased to 0.74 Cr in March 2025, up from 0.14 Cr in March 2024, primarily driven by other expenses. This led to an operating profit (PBDIT) of -0.55 Cr in March 2025, reflecting a negative operating profit margin of -289.47%. The profit before...

Why is Boston Bio falling/rising?

2025-11-08 00:04:20

As of 07-Nov, Boston Bio Systems Ltd is experiencing a decline in its stock price, currently at 7.75, which represents a decrease of 0.37 or 4.56%. The stock has been underperforming, having fallen consecutively for the last two days and showing a total return of -8.82% over the past week. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. There has also been a significant drop in investor participation, with delivery volume on 06 Nov falling by 59.78% compared to the 5-day average. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement. In the broader market context, Boston Bio's short-term performance has significantly lagged behind the benchmark, the Sensex, which has only decreased by 0.86% over the same week. While the Sensex has sho...

Why is Boston Bio falling/rising?

2025-10-30 23:26:17

As of 30-Oct, Boston Bio Systems Ltd's stock price is currently at 8.39, reflecting an increase of 0.39 or 4.88%. The stock has shown strong performance recently, gaining 14.62% over the last three days and outperforming its sector by 3.91% today. The stock's delivery volume has also seen a significant rise of 160.05% compared to the 5-day average, indicating increased investor participation. Additionally, the stock is trading above its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below the 200-day moving average. There are no positive or negative factors explicitly mentioned, but the overall trends suggest a favorable sentiment towards the stock. In the broader market context, Boston Bio's stock has outperformed the Sensex over the past week, with a return of +8.96% compared to the benchmark's slight decline of -0.18%. However, over the past month, while Boston Bio has gained +4...

Why is Boston Bio falling/rising?

2025-10-15 23:34:50

As of 15-Oct, Boston Bio Systems Ltd is experiencing a decline in its stock price, currently at 7.63, which reflects a decrease of 0.4 or 4.98%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total decline of 9.7% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The delivery volume has also decreased significantly, down by 42.38% compared to the 5-day average, suggesting a reduction in investor participation. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's recent movement. In the broader market context, Boston Bio's performance over the past week shows a substantial decline of 15.88%, while the benchmark Sensex has increased by 1.02%. This stark contrast highlights the stock's underpe...

Why is Boston Bio falling/rising?

2025-10-10 23:19:23

As of 10-Oct, Boston Bio Systems Ltd's stock price is currently at 8.19, reflecting a decline of 0.43, or 4.99%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total drop of 9.7% during this period. Additionally, the stock's performance today has lagged behind its sector by 4.55%. In terms of returns, the stock has decreased by 7.67% over the past week and 1.80% over the past month, while there is no year-to-date or yearly return data available. Notably, investor participation has also diminished, with delivery volume dropping by 70.28% compared to the five-day average, indicating a lack of interest among investors. Broader Market Context: In contrast, the benchmark Sensex has shown positive movement, gaining 1.59% over the past week and 1.32% over the past month. This stark difference highlights the stock's underperformance relative to the broader mar...

Why is Boston Bio falling/rising?

2025-10-06 23:17:24

As of 06-Oct, Boston Bio Systems Ltd's stock price is currently at 9.00, reflecting an increase of 0.13 or 1.47%. The stock has shown strong performance recently, gaining 11.8% over the last three days and outperforming its sector by 2.03% today. Additionally, the stock has experienced a significant rise in investor participation, with delivery volume increasing by 294.72% compared to the five-day average. The stock's returns over the past week and month are also notable, with increases of 10.16% and 4.77%, respectively, indicating positive momentum. There is no information available regarding positive or negative factors that could influence the stock's movement. In the broader market context, Boston Bio's short-term performance has significantly outpaced the benchmark, the Sensex, which has only risen by 1.77% over the past week and 1.34% over the past month. This strong relative performance suggests tha...

Why is Boston Bio falling/rising?

2025-09-25 23:28:15

As of 25-Sep, Boston Bio Systems Ltd is currently priced at 8.40, reflecting an increase of 0.07 or 0.84%. The stock has been on a positive trajectory, gaining for the last three days with a total return of 9.38% during this period. However, it has underperformed its sector by 1.54% today. In terms of benchmark performance, the stock has shown a weekly return of +0.60% compared to the Sensex's decline of -2.23%, and a monthly return of +2.44% against the Sensex's -0.58%. Notably, the stock's delivery volume has decreased significantly, falling by 53.15% against the 5-day average, indicating a drop in investor participation, which could be a concern for future price movements. Broader Market Context: The broader market context shows that the Medical Equipment/Supplies/Accessories sector has gained by 2.4%, which may provide a supportive backdrop for Boston Bio's recent gains. Despite this, the stock's perfo...

Why is Boston Bio falling/rising?

2025-09-23 23:30:43

As of 23-Sep, Boston Bio Systems Ltd's stock price is currently at 7.95, reflecting an increase of 0.27 or 3.52%. The stock has shown a trend reversal, gaining after two consecutive days of decline. Additionally, it has outperformed its sector by 3.94% today. The stock's delivery volume has significantly increased by 207.14% compared to the 5-day average, indicating rising investor participation. Although the stock is trading higher than its 50-day and 100-day moving averages, it remains lower than the 5-day, 20-day, and 200-day moving averages. There are no positive or negative factors provided to further explain the stock's recent movement. In the broader market context, the stock's performance over the past week shows a decline of 0.62%, while the Sensex has decreased by only 0.34%, indicating that Boston Bio has underperformed relative to the benchmark in the short term. Over the past month, the stock ...

Why is Boston Bio falling/rising?

2025-09-22 23:21:04

As of 22-Sep, Boston Bio Systems Ltd is experiencing a decline in its stock price, currently at 7.65, which reflects a decrease of 0.17 or 2.17%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total return of -8.38% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The stock has also shown a significant drop in investor participation, with delivery volume plummeting by 93.94% against the 5-day average. There is no information available regarding positive or negative factors that could influence the stock's recent movement. In the broader market context, Boston Bio's performance over the past week shows a decline of 4.97%, while the benchmark Sensex has increased by 0.46%. This stark contrast highlights the stock's underperformance relative to the market. Ov...

View All News